Description
A thiazolamine that inhibits LTB4 synthesis in human neutrophils (IC50 = ~0.5 µM) and conversion of LTA4 to LTB4 by purified LTA4 hydrolase (Ki = 2.3 µM); does not significantly affect the hydrolysis of Pro-Gly-Pro by LTA4 hydrolase
Formal name: 4-[4-(phenylmethyl)phenyl]-2-thiazolamine
Synonyms:
Molecular weight: 268.4
CAS: 68729-05-5
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Leukotrienes||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Lipoxygenase Pathways